help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mezosi, E.
Right arrow Articles by Baker, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mezosi, E.
Right arrow Articles by Baker, J. R., Jr.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 1 250-257
Copyright © 2004 by The Endocrine Society

Interleukin-1ß and Tumor Necrosis Factor (TNF)-{alpha} Sensitize Human Thyroid Epithelial Cells to TNF-Related Apoptosis-Inducing Ligand-Induced Apoptosis through Increases in Procaspase-7 and Bid, and the Down-Regulation of p44/42 Mitogen-Activated Protein Kinase Activity

Emese Mezosi, Su He Wang, Saho Utsugi, Laszlo Bajnok, James D. Bretz, Paul G. Gauger, Norman W. Thompson and James R. Baker, Jr.

Center for Biologic Nanotechnology (J.R.B.) and the Departments of Medicine (E.M., S.H.W., S.U., J.D.B., J.R.B.), Physiology (L.B.), and Surgery (P.G.G., N.W.T.), University of Michigan Medical Center, Ann Arbor, Michigan 48109

Address all correspondence and requests for reprints to: James R. Baker, Jr., M.D., University of Michigan Medical Center, 9220 MSRB III, 1150 West Medical Center Drive, Ann Arbor, Michigan 48109-0648. E-mail: jbakerjr{at}umich.edu.

Primary thyroid cells are resistant to TNF-related apoptosis-inducing ligand (TRAIL). Previously we showed that the combination of IL-1ß and TNF{alpha} facilitated TRAIL-mediated apoptosis in these cells and enhanced cell surface expression of TRAIL receptors. The aim of this study was to further characterize the mechanism by which these cytokines sensitized primary thyroid cells to TRAIL-mediated apoptosis. IL-1ß and TNF{alpha} increased the concentrations of procaspase-7 and Bid. In contrast, the p44/42 MAPK (Erk) pathway was active in thyroid cells and this activity was significantly decreased after exposure to IL-1ß/TNF{alpha}. A MAPK kinase inhibitor (U0126) could enhance the cytokine-induced sensitization of thyroid cells to TRAIL, reinforcing the inhibitory role of Erk on TRAIL signaling. In conclusion, IL-1ß/TNF{alpha} treatment sensitizes human thyroid cells to TRAIL-mediated apoptosis through increased surface expression of TRAIL receptors, increased expression of procaspase-7 and Bid, and the inhibition of p44/42 MAPK (Erk) pathway.

This work was supported by National Institutes of Health Grants R01 A137141 and P60DK20572.

Abbreviations: cFLIP, Cellular FADD-like IL-1ß converting enzyme inhibitory protein; DcR, decoy receptor; DR, death receptor; IAP, inhibitor of apoptosis protein; IFN, interferon; MEK, MAPK kinase; NF-{kappa}B, nuclear factor {kappa}B; NP-40, Nonidet-P40; p90RSK, ribosomal S6 kinase; TEC, thyroid epithelial cell; TRAIL, TNF-related apoptosis-inducing ligand.




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. A. O'Brien, M. A. Richardson, S. F. Mehrbod, D. T. Berg, B. Gerlitz, A. Gupta, and B. W. Grinnell
Activated Protein C Decreases Tumor Necrosis Factor Related Apoptosis-Inducing Ligand by an EPCR- Independent Mechanism Involving Egr-1/Erk-1/2 Activation
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2634 - 2641.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Z.-X. Du, H.-Q. Wang, H.-Y. Zhang, and D.-X. Gao
Involvement of Glyceraldehyde-3-Phosphate Dehydrogenase in Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Death of Thyroid Cancer Cells
Endocrinology, September 1, 2007; 148(9): 4352 - 4361.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Chiappetta, M. Ammirante, A. Basile, A. Rosati, M. Festa, M. Monaco, E. Vuttariello, R. Pasquinelli, C. Arra, M. Zerilli, et al.
The Antiapoptotic Protein BAG3 Is Expressed in Thyroid Carcinomas and Modulates Apoptosis Mediated by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1159 - 1163.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A.-C. Gerard, M. Boucquey, M.-F. van den Hove, and I. M. Colin
Expression of TPO and ThOXs in human thyrocytes is downregulated by IL-1{alpha}/IFN-{gamma}, an effect partially mediated by nitric oxide
Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E242 - E253.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
E. Mezosi, S. H. Wang, S. Utsugi, L. Bajnok, J. D. Bretz, P. G. Gauger, N. W. Thompson, and J. R. Baker Jr.
Induction and Regulation of Fas-Mediated Apoptosis in Human Thyroid Epithelial Cells
Mol. Endocrinol., March 1, 2005; 19(3): 804 - 811.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society